Biotechnology — US sector stocks, live prices and news
Constituents · 30
- 1
AbbVie Inc. Common StockABBV$390B
- 2
AmgenAMGN$186B
- 3
Thermo Fisher Scientific Inc Common StockTMO$175B
- 4
Gilead SciencesGILD$160B
- 5
Vertex Pharmaceuticals IncorporatedVRTX$113B
- 6
Regeneron PharmaceuticalsREGN$64B
- 7
argenx SEARGX$52B
- 8
Alnylam PharmaceuticalsALNY$41B
- 9
Agilent Technologies, Inc. Common StockA$40B
- 10
Waters Corporation Common StockWAT$38B
- 11
NateraNTRA$33B
- 12
BiogenBIIB$29B
- 13
IlluminaILMN$27B
- 14
Mettler-Toledo International, Inc. Common StockMTD$24B
- 15
United TherapeuticsUTHR$23B
- 16
Insmed IncorporatedINSM$23B
- 17
ModernaMRNA$20B
- 18
IncyteINCY$20B
- 19
Neurocrine BiosciencesNBIX$17B
- 20
Genmab A/SGMAB$15B
- 21
Ascendis Pharma A/S - Ordinary ShareASND$14B
- 22
BridgeBio PharmaBBIO$13B
- 23
Medpace HoldingsMEDP$13B
- 24
ExelixisEXEL$13B
- 25
Ionis PharmaceuticalsIONS$12B
- 26
ICONICLR$12B
- 27
Summit TherapeuticsSMMT$11B
- 28
BioMarin PharmaceuticalBMRN$11B
- 29
Arrowhead PharmaceuticalsARWR$10B
- 30
BrukerBRKR$10B
Latest Biotechnology news · 10
Eli Lilly, Regeneron Among First Seven in FDA's Manufacturing PreCheck Pilot — the Supply Chain Acceleration Markets Are UnderpricingJun 30, 2026
Parabilis IPO Pops Bigger Than SpaceX as Regeneron (REGN) Backs the BiotechJun 28, 2026
BioLife Solutions (BLFS) Draws Repligen (RGEN) Takeover Interest as Bioprocessing ConsolidatesJun 28, 2026
Viridian (VRDN) Wins First FDA Approval, Enters Thyroid Eye Disease Market Against AmgenJun 28, 2026
AbbVie Skyrizi Wins Pediatric Psoriatic Disease Label, Extending Post-Humira Runway (ABBV)Jun 27, 2026
UPS Bets $48M on Cold-Chain Logistics: A Margin Play on the Healthcare BoomJun 23, 2026
AbbVie (ABBV) Eyes $10.9B Biotech Buyout to Add Eczema Drug, Pressuring DupixentJun 21, 2026
Zealand Pharma (ZLDPF) Stock Swings Signal Amylin Pivot in Weight-Loss Race vs LLY, NVOJun 19, 2026
US Tariff Probe Into Germany Drug Pricing: What It Means for PFE, MRK, LLY Pharma StocksJun 19, 2026
Adaptive Biotechnologies (ADPT): What an Insider's ~40,000-Share Sale Signals to InvestorsJun 15, 2026About Biotechnology
The Biotechnology sector includes 199 listed US companies with a combined market capitalization of $1.84T. Its largest constituent is AbbVie Inc. Common Stock (ABBV). Below are the biggest Biotechnology stocks and the latest news across them.
What are the largest Biotechnology stocks?
The biggest US Biotechnology companies by market cap include AbbVie Inc. Common Stock (ABBV), Amgen (AMGN), Thermo Fisher Scientific Inc Common Stock (TMO), Gilead Sciences (GILD), Vertex Pharmaceuticals Incorporated (VRTX). The full ranked list is shown above.
How big is the US Biotechnology sector?
The Biotechnology sector spans 199 listed US companies with a total market capitalization of about $1.84T.
Where can I see Biotechnology news?
The latest stories across Biotechnology companies are listed in the news section on this page, updated as they are published.
Live quotes update during US trading hours; the last close is shown otherwise. Market capitalization is aggregated from listed US companies and provided for information only — not investment advice.